Skip to content

Comparison of Hemodynamic Stability and Organ Protective Effects of Ciprofol and Propofol for Sedation in Patients Undergoing Mechanical Ventilation after Acute Type A Aortic Dissection Surgery: A Multicenter Randomized Controlled Trial

Comparison of Hemodynamic Stability and Organ Protective Effects of Ciprofol and Propofol for Sedation in Patients Undergoing Mechanical Ventilation after Acute Type A Aortic Dissection Surgery: A Multicenter Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121122
Enrollment
Unknown
Registered
2026-03-25
Start date
2026-04-15
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Type A Aortic Dissection

Interventions

Ciprofol group:After the patient emerges from general anesthesia and is assessed to have no disturbance of consciousness, with a Richmond Agitation-Sedation Scale (RASS) score greater than 0, analgesi

Sponsors

Henan Provincial Chest Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Patients undergoing invasive mechanical ventilation following aortic dissection surgery with cardiopulmonary bypass. 2.Glasgow Coma Scale (GCS) score > 8. 3.No postoperative disturbance of consciousness, with a target Richmond Agitation-Sedation Scale (RASS) score of -2 to 0, and an expected sedation duration of 6 to 48 hours after randomization. 4.Age between 18 and 75 years (inclusive). 5.Signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Pregnant or breastfeeding women. 2.Severe pre-existing parenchymal liver disease with clinically significant portal hypertension, Child-Pugh Class C cirrhosis, or acute liver failure. 3.Dissection involving the head and neck vessels or pre-existing encephalopathy before surgery. 4.Patients with bronchial asthma, chronic obstructive pulmonary disease (COPD), or myasthenia gravis. 5.Patients with a history of alcohol or drug abuse. 6.Inability to obtain informed consent or authorization. 7.Patients not requiring sedation or analgesia therapy. 8.Mean arterial pressure (MAP) < 55 mmHg. 9.Receipt of two or more types of sedative or analgesic medications within 24 hours. 10.Patients with a known allergy to propofol, ciprofol, or remifentanil hydrochloride.

Design outcomes

Primary

MeasureTime frame
Area under the curve of mean arterial pressure change from baseline (MAP-AUC);

Secondary

MeasureTime frame
Total vasopressor dose (norepinephrine equivalent);Incidence of acute kidney injury (AKI);Serum inflammatory markers (interleukin-6, IL-6) levels;Duration of mechanical ventilation;Incidence of delirium;

Countries

China

Contacts

Public ContactHe Faming

Henan Provincial Chest Hospital of Zhengzhou University

65088797@qq.com+86 136 7350 0996

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 4, 2026